Pivagabine is an antiepileptic medication used to treat partial-onset seizures in adults with epilepsy. It is available in tablet and solution form and has been found to be effective in reducing the frequency and intensity of seizures and improving overall health. Pivagabine works by increasing the amount of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain. This helps to reduce the abnormal electrical activity that causes seizures. Common side effects of Pivagabine include drowsiness, dizziness, fatigue, blurred vision, and nausea.
Pivagabine, also known by the brand name Tonerg, is a medication that was once used as an antidepressant and anti-anxiety medication. It was introduced in Italy in 1997 but is no longer used there.
Pivagabine was originally believed to work by increasing levels of gamma-aminobutyric acid (GABA) in the brain. GABA is a chemical messenger that helps nerve cells calm down. However, it is now believed to work in a different way.
Pivagabine is thought to work by modulating corticotropin-releasing factor (CRF). CRF is a hormone that is released by the hypothalamus in the brain in response to stress. It plays a role in the body's stress response and is involved in anxiety and depression.
Pivagabine was discontinued because it was found to have a number of side effects, including drowsiness, dizziness, and movement problems. It was also not as effective as other antidepressants and anti-anxiety medications.